I

Irmandade da Santa Casa de Misericordia de Sao Paulo | Hospital Central - Cardiology Department

Research site

(Unclaimed)

Location

112 Doutor Cesareo Mota Junior, São Paulo, São Paulo, Brazil

Site insights

Top conditions

Top treatments

Pimodivir

Tenecteplase

LOXO-305

Milvexian

TAR-210

Parent organization

This site is a part of Irmandade da Santa Casa de Misericordia de Sao Paulo

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 7 total trials

A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer (MoonRISe-1)

The main purpose of this study is to compare the disease-free survival between participants receiving treatment with TAR-210 versus investigator's ch...

Enrolling

Non-Muscle Invasive Bladder Neoplasms

Drug: Gemcitabine

Combination Product: TAR-210

Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL) (BRUIN-MCL-321)

This is a study for participants with a type of blood cancer called mantle cell lymphoma (MCL). The main purpose is to compare pirtobrutinib (LOXO-30...

Active, not recruiting

Lymphoma, Mantle-Cell

Drug: Ibrutinib

Drug: Pirtobrutinib

Trial sponsors

U

H

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms